Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Industrials · ·
$10.53
▼ $0.45 (-4.1%)
Market data updated: 09/19 05:42 AM
Fundamentals updated: 09/18/2026
News analyzed: 09/19/2026
Market Cap
$435.24M
Day Range
$10.26 - $10.98
52-Week Range
$5.03 - $11.25
Beta
—
Next Earnings
09.11.2026
Support
$6.90
Resistance
$11.25
MASS is a stock from the Industrials sector — Manufacturing, aerospace, defense, and infrastructure — closely tied to capital-investment cycles and economic growth.
+68.1% (1Y)
Strengths: 17/29 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟢 Bullish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Earnings per share (EPS) growth
Earnings per share (EPS) growth: 125.5%
Growth
Biggest negative driver
DCF Fair Value
Estimated fair value: -$11.89 vs. price $10.53 (-212.9%)
Fair Value
Signal tension
Growth scores strong (79/100), but fair-value analysis scores this stock as relatively expensive (38/100) — the growth story and the current price aren't fully aligned.
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
65
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
79
Quality
42
Value
38
Momentum
74
Risk
40
Sentiment
100
Fundamental
63
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of **908 Devices Inc.** has centered on its expanding focus on handheld chemical detection tools, particularly for health, safety, and defense applications. The company highlighted strong Q2 2026 results, including revenue growth, reduced losses, and rising recurring revenue, reinforcing its outlook for market demand. CEO Kevin Knopp emphasized strategic expansion at industry conferences, including the Midwest IDEAS event, while analysts noted its momentum and potential as a high-growth small-cap stock. Upcoming participation in the Gabelli Aerospace & Defense Symposium further underscores its industry positioning.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about 908 Devices Inc.. News trend score: 100. Reason: 13 of the last 20 articles are positive, versus 0 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
47
🎯 Conviction (vs. Emotion)
38
Psychology
54
Fundamentals
63
Technical
74
Valuation
38
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The price rise has far outpaced the actual improvement in fundamental data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
+24%
Market Narrative
68
Fundamental Reality
38
Narrative Gap
+30
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The dominant herding behavior in MASS reflects a market aligning with peer performance rather than independent conviction. The narrative gap (21-point divergence) suggests traders may be overestimating positive fundamentals relative to price action, despite neutral technical signals. The lack of extreme volatility or volume rules out panic or FOMO as primary drivers. The key question is whether the stock’s underperformance today signals a broader sector rotation or a temporary disconnect from fundamentals.
Updated: 09/09/2026, 06:44 AM
What could change this?
👥 What the crowd believes
"expansion in handheld chemical detection following second-quarter 2026 results that showed revenue growth"
"narrower adjusted EBITDA loss and increasing recurring revenue"
"another revenue beat in Q2... raised guidance"
"MASS stock is a Buy... rated Buy after a 2Q26 earnings beat"
📈 8D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Walter Bagehot — 100/100
🔴 Weakest match
Samuel Armstrong Nelson — 11/100
🗣️ Why do they disagree?
The stark divide in verdicts for this stock reflects deep methodological differences in how these investors assess risk, growth, and valuation. At the top, Bagehot’s near-perfect score highlights its liquidity and resilience in crises, aligning with his focus on financial stability, while Nelson and Lynch see strong growth potential—Nelson from a cyclical perspective and Lynch from a valuation lag. Meanwhile, Fisher’s mid-tier score suggests it’s a solid but unexceptional business, contrasting sharply with Marks’ and Loeb’s low scores, which flag valuation and risk concerns as dealbreakers. The middle-ground methodologies—like Smith, Schwager, and Housel—acknowledge some merit but lack clear conviction, while the efficient-market camp dismisses it as unworthy of active picking. This tension between liquidity/liability (Bagehot), growth (Lynch/Nelson), and risk/valuation (Marks/Loeb) underscores how the same stock can be either a defensive anchor or a speculative gamble depending on the framework.
Walter Bagehot
Lombard Street (1873)
🟢 100
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 83
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 63
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 56
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 49
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 46
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 46
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 45
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 39
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 38
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 35
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 32
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🔴 28
Looks late-cycle — the position Marks would treat with extra caution
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🔴 26
Pattern consistent with a crowd delusion Mackay would flag
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🔴 18
Risk/valuation combination Marks would flag as a caution sign
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 11
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Based on the last 279 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (8 bullish · 3 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
High confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
50.6%
Operating Margin
-70.1%
Net Margin
34.7%
EBITDA Margin
-62.2%
ROE
13.6%
ROA
10.3%
ROIC
—
EPS
$0.54
Cash
$70.52M
Total Debt
—
Current Ratio
4.24
Debt/Equity
—
How is Fair Value calculated? →
Current Price
$10.53
Estimated Fair Value (DCF)
-$11.89
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-212.9%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
6.7%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 6.7% | $-26.28M | $-24.11M |
| 2 | 5.6% | $-27.76M | $-23.36M |
| 3 | 4.6% | $-29.03M | $-22.42M |
| 4 | 3.5% | $-30.06M | $-21.29M |
| 5 | 2.5% | $-30.81M | $-20.02M |
Base FCF (last actual year)
$-24.64M
Terminal Value
$-485.82M
Present Value of Terminal Value
$-315.75M
Enterprise Value
$-426.96M
Net Debt
$0
Equity Value
$-426.96M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$4.00
Tangible Book Value per Share (Tangible NAV)
$2.99
Sentiment based on basic keywords (not AI) — 13 positive, 7 neutral, 0 negative out of the last 20 articles.
Benzinga · 18.9.2026
MT Newswires · 10.9.2026
Benzinga · 10.9.2026
Yahoo · 1.9.2026
Business Wire · 1.9.2026
SeekingAlpha · 30.8.2026
Yahoo · 30.8.2026
MarketBeat · 30.8.2026
Motley Fool · 18.8.2026
ChartMill · 18.8.2026
MarketBeat · 18.8.2026
MarketBeat · 15.8.2026
SeekingAlpha · 13.8.2026
GuruFocus.com · 13.8.2026
SeekingAlpha · 12.8.2026
Benzinga · 12.8.2026
Benzinga · 12.8.2026
Business Wire · 12.8.2026
Moby · 12.8.2026
SeekingAlpha · 11.8.2026
908 Devices Inc. (MASS) currently has a StockIQ AI score of 65/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
MASS currently scores 65/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, MASS's estimated fair value is -$11.89, which is 212.9% below the current price of $10.53. This is one valuation model among several signals in the fair-value category, not a price target.
MASS's technical score is 74/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Earnings per share (EPS) growth: 125.5%; Free cash flow growth: 20.1%; Net income growth: 127.0%.
Based on the real signals StockIQ computed: Estimated fair value: -$11.89 vs. price $10.53 (-212.9%); Operating margin: -70.1% (negative); Operating margin is eroding over time.
StockIQ has no recorded dividend payment history for MASS.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 25 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Brown Christopher D. | Open Market Sale | 2.9.2026 | 30,000 | -30,000 | $10.58 |
| Griffith Joseph H. IV | Open Market Sale | 25.8.2026 | 121,497 | -11,459 | $10.95 |
| Griffith Joseph H. IV | Open Market Sale | 25.8.2026 | 11,459 | -11,459 | $10.95 |
| AWM Investment Company, Inc. | Open Market Sale | 21.8.2026 | 4,779,773 | -41,578 | $10.61 |
| AWM Investment Company, Inc. | Open Market Sale | 21.8.2026 | 41,578 | -41,578 | $10.61 |
| AWM Investment Company, Inc. | Open Market Sale | 20.8.2026 | 4,821,351 | -8,422 | $10.52 |
| AWM Investment Company, Inc. | Open Market Sale | 20.8.2026 | 8,422 | -8,422 | $10.52 |
| Knopp Kevin J. | Open Market Sale | 17.8.2026 | 20,000 | -20,000 | $10.35 |
| Knopp Kevin J. | Open Market Sale | 13.8.2026 | 7,622 | -7,622 | $10.06 |
| Knopp Kevin J. | Open Market Sale | 12.8.2026 | 2,747 | -2,747 | $10.07 |
| Knopp Kevin J. | Open Market Sale | 12.8.2026 | 583,590 | -2,747 | $10.07 |
| Brown Christopher D. | Open Market Sale | 11.8.2026 | 8,358 | -8,358 | $9.23 |
| Knopp Kevin J. | Open Market Sale | 11.8.2026 | 30,170 | -30,170 | $10.16 |
| Knopp Kevin J. | Open Market Sale | 11.8.2026 | 115,748 | -115,748 | $9.83 |
| Knopp Kevin J. | Open Market Sale | 11.8.2026 | 616,507 | -115,748 | $9.83 |
| Knopp Kevin J. | Open Market Sale | 11.8.2026 | 586,337 | -30,170 | $10.16 |
| Brown Christopher D. | Open Market Sale | 11.8.2026 | 805,559 | -8,358 | $9.23 |
| Brown Christopher D. | Open Market Sale | 10.8.2026 | 9,442 | -9,442 | $9.03 |
| Knopp Kevin J. | Open Market Sale | 10.8.2026 | 348 | -348 | $9.06 |
| Knopp Kevin J. | Open Market Sale | 10.8.2026 | 732,255 | -348 | $9.06 |
| Brown Christopher D. | Open Market Sale | 10.8.2026 | 813,917 | -9,442 | $9.03 |
| Brown Christopher D. | Open Market Sale | 5.8.2026 | 20,000 | -20,000 | $8.49 |
| Brown Christopher D. | Open Market Sale | 5.8.2026 | 823,359 | -20,000 | $8.49 |
| AWM Investment Company, Inc. | Open Market Sale | 4.8.2026 | 50,000 | -50,000 | $8.36 |
| AWM Investment Company, Inc. | Open Market Sale | 4.8.2026 | 4,829,773 | -50,000 | $8.36 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
2,809,467 shares short as of 2026-08-31 · vs. 3,389,065 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
70.1% of trading volume this week was short selling, vs. 68.5% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology